speb/financial-data huggingface dataset:
IVDA income_statement (annual, 2023-12-31) — EBIT: -4117104.00
IVDA income_statement (annual, 2023-12-31) — EBITDA: -4097351.00
IVDA income_statement (annual, 2023-12-31) — Earnings From Equity Interest: -180000.00
IVDA cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 180000.00
IVDA cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 1780.00
IVDA cash_flow (annual, 2023-12-31) — End Cash Position: 4868282.00
IVDA cash_flow (annual, 2023-12-31) — Financing Cash Flow: 1023833.00
IVDA cash_flow (annual, 2023-12-31) — Free Cash Flow: -3418953.00
IVDA cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 2700.00
IVDA balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -221418.00
IVDA income_statement (annual, 2023-12-31) — General And Administrative Expense: 4311367.00
IVDA balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 281049.00
IVDA income_statement (annual, 2023-12-31) — Gross Profit: 1067604.00
IVDA cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 28779.00
IVDA income_statement (annual, 2023-12-31) — Interest Expense: 7254.00
IVDA income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 7254.00
IVDA income_statement (annual, 2023-12-31) — Interest Income: 131870.00
IVDA income_statement (annual, 2023-12-31) — Interest Income Non Operating: 131870.00
IVDA cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 9793.00
IVDA balance_sheet (annual, 2023-12-31) — Inventory: 324515.00
IVDA balance_sheet (annual, 2023-12-31) — Invested Capital: 4997251.00
IVDA cash_flow (annual, 2023-12-31) — Investing Cash Flow: -265593.00
IVDA cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 1322885.00
IVDA balance_sheet (annual, 2023-12-31) — Line Of Credit: 348771.00
IVDA cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -180000.00
IVDA cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 1322885.00
IVDA income_statement (annual, 2023-12-31) — Net Income: -4142666.00
IVDA income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -4142666.00
IVDA income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -4142666.00
IVDA income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -4142666.00
IVDA income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -4142666.00
IVDA cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -4142666.00
IVDA income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -4142666.00
IVDA income_statement (annual, 2023-12-31) — Net Interest Income: 124616.00
IVDA cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -299052.00
IVDA cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -251498.00
IVDA income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 124616.00
IVDA cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -99733.00
IVDA balance_sheet (annual, 2023-12-31) — Net PPE: 98575.00
IVDA cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -85593.00
IVDA cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -47554.00
IVDA balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 4648480.00
IVDA income_statement (annual, 2023-12-31) — Normalized EBITDA: -4097351.00
IVDA income_statement (annual, 2023-12-31) — Normalized Income: -4142666.00
IVDA cash_flow (annual, 2023-12-31) — Operating Cash Flow: -3333360.00
IVDA cash_flow (annual, 2023-12-31) — Operating Gains Losses: 182700.00
IVDA income_statement (annual, 2023-12-31) — Operating Income: -4040875.00
IVDA income_statement (annual, 2023-12-31) — Operating Revenue: 6495865.00
IVDA balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 2021236.00
IVDA balance_sheet (annual, 2023-12-31) — Other Current Assets: 1.00
IVDA balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -221418.00
IVDA balance_sheet (annual, 2023-12-31) — Other Equity Interest: -99048.00
IVDA income_statement (annual, 2023-12-31) — Other Gand A: 4311367.00
IVDA income_statement (annual, 2023-12-31) — Other Income Expense: -208099.00
IVDA cash_flow (annual, 2023-12-31) — Other Non Cash Items: 138546.00
IVDA balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 298163.00
IVDA balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1.00
IVDA income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -28099.00
IVDA balance_sheet (annual, 2023-12-31) — Payables: 1308914.00
IVDA balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1308914.00
IVDA balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
IVDA balance_sheet (annual, 2023-12-31) — Prepaid Assets: 435581.00
IVDA income_statement (annual, 2023-12-31) — Pretax Income: -4124358.00
IVDA cash_flow (annual, 2023-12-31) — Purchase Of Business: -180000.00
IVDA cash_flow (annual, 2023-12-31) — Purchase Of PPE: -85593.00
IVDA balance_sheet (annual, 2023-12-31) — Receivables: 281049.00
IVDA income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 5428261.00
IVDA income_statement (annual, 2023-12-31) — Reconciled Depreciation: 19753.00
IVDA income_statement (annual, 2023-12-31) — Research And Development: 797112.00
IVDA balance_sheet (annual, 2023-12-31) — Restricted Cash: 129778.00
IVDA balance_sheet (annual, 2023-12-31) — Retained Earnings: -49195897.00
IVDA income_statement (annual, 2023-12-31) — Selling General And Administration: 4311367.00
IVDA balance_sheet (annual, 2023-12-31) — Share Issued: 2021236.00
IVDA cash_flow (annual, 2023-12-31) — Stock Based Compensation: 104600.00
IVDA balance_sheet (annual, 2023-12-31) — Stockholders Equity: 4648480.00
IVDA balance_sheet (annual, 2023-12-31) — Tangible Book Value: 4648480.00
IVDA income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
IVDA income_statement (annual, 2023-12-31) — Tax Provision: 18308.00
IVDA income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
IVDA balance_sheet (annual, 2023-12-31) — Total Assets: 6306165.00
IVDA balance_sheet (annual, 2023-12-31) — Total Capitalization: 4648480.00
IVDA balance_sheet (annual, 2023-12-31) — Total Debt: 348771.00
IVDA balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 4648480.00
IVDA income_statement (annual, 2023-12-31) — Total Expenses: 10536740.00
IVDA balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1657685.00
IVDA balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 396738.00
IVDA balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
IVDA income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -4040875.00
IVDA balance_sheet (annual, 2023-12-31) — Working Capital: 4251742.00
IVDA balance_sheet (quarterly, 2024-09-30) — Allowance For Doubtful Accounts Receivable: 0.00
IVDA income_statement (quarterly, 2024-09-30) — Basic Average Shares: 2115307.00
IVDA income_statement (quarterly, 2024-09-30) — Basic EPS: -0.27
IVDA cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -339339.00
IVDA balance_sheet (quarterly, 2024-09-30) — Current Accrued Expenses: 666049.00
IVDA income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 2115307.00
IVDA income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.27
IVDA balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 1131962.00
IVDA balance_sheet (quarterly, 2024-09-30) — Gross Accounts Receivable: 2158971.00
IVDA balance_sheet (quarterly, 2024-09-30) — Minority Interest: -132605.00
IVDA income_statement (quarterly, 2024-09-30) — Minority Interests: 19331.00
IVDA cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: 0.00
IVDA balance_sheet (quarterly, 2024-09-30) — Prepaid Assets: 548312.00
IVDA cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: 11.00
IVDA cash_flow (quarterly, 2024-09-30) — Stock Based Compensation: 0.00
IVDA balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 50157.00
IVDA income_statement (annual, 2024-12-31) — +Operating Expense: 5371937.00
IVDA income_statement (annual, 2024-12-31) — +Total Revenue: 6020639.00
IVDA balance_sheet (annual, 2024-12-31) — Accounts Payable: 1748857.00
IVDA balance_sheet (annual, 2024-12-31) — Accounts Receivable: 1277635.00
IVDA balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 55962337.00
IVDA income_statement (annual, 2024-12-31) — Basic Average Shares: 2203893.00
IVDA income_statement (annual, 2024-12-31) — Basic EPS: -1.81
IVDA cash_flow (annual, 2024-12-31) — Beginning Cash Position: 4868282.00
IVDA cash_flow (annual, 2024-12-31) — Capital Expenditure: -2608.00
IVDA balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 0.00
IVDA balance_sheet (annual, 2024-12-31) — Capital Stock: 28.00
IVDA balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 2629287.00
IVDA balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 2629287.00
IVDA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 2260419.00
IVDA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -2608.00
IVDA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -4419748.00
IVDA cash_flow (annual, 2024-12-31) — Change In Inventory: 176395.00
IVDA cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 204221.00
IVDA cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -507308.00
IVDA cash_flow (annual, 2024-12-31) — Change In Payable: 439945.00
IVDA cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 439945.00
IVDA cash_flow (annual, 2024-12-31) — Change In Receivables: -996586.00
IVDA cash_flow (annual, 2024-12-31) — Change In Working Capital: -683333.00
IVDA cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -996586.00
IVDA cash_flow (annual, 2024-12-31) — Changes In Cash: -2161937.00
IVDA balance_sheet (annual, 2024-12-31) — Common Stock: 28.00
IVDA balance_sheet (annual, 2024-12-31) — Common Stock Equity: 2505439.00
IVDA cash_flow (annual, 2024-12-31) — Common Stock Issuance: 1683970.00
IVDA income_statement (annual, 2024-12-31) — Cost Of Revenue: 4719005.00
IVDA balance_sheet (annual, 2024-12-31) — Current Assets: 5026415.00
IVDA balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 0.00
IVDA balance_sheet (annual, 2024-12-31) — Current Debt: 549032.00
IVDA balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 549032.00
IVDA balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 507308.00
IVDA balance_sheet (annual, 2024-12-31) — Current Liabilities: 2297889.00
IVDA cash_flow (annual, 2024-12-31) — Depreciation: 31805.00
IVDA cash_flow (quarterly, 2024-12-31) — Depreciation: 7999.00
IVDA cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 31805.00
IVDA cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 31805.00
IVDA income_statement (annual, 2024-12-31) — Diluted Average Shares: 2203893.00
IVDA income_statement (annual, 2024-12-31) — Diluted EPS: -1.81
IVDA income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -3980820.00
IVDA income_statement (annual, 2024-12-31) — EBIT: -3922252.00
IVDA income_statement (annual, 2024-12-31) — EBITDA: -3890447.00
IVDA income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 0.00
IVDA cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 0.00
IVDA cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -48045.00
IVDA cash_flow (annual, 2024-12-31) — End Cash Position: 2658300.00
IVDA cash_flow (annual, 2024-12-31) — Financing Cash Flow: 2260419.00
IVDA cash_flow (annual, 2024-12-31) — Free Cash Flow: -4422356.00
IVDA balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -280209.00
IVDA income_statement (annual, 2024-12-31) — General And Administrative Expense: 5008587.00
IVDA balance_sheet (annual, 2024-12-31) — Gross PPE: 68677.00
IVDA income_statement (annual, 2024-12-31) — Gross Profit: 1301634.00
IVDA cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 38544.00
IVDA income_statement (annual, 2024-12-31) — Interest Expense: 26183.00
IVDA income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 26183.00
IVDA income_statement (annual, 2024-12-31) — Interest Income: 113728.00
IVDA income_statement (annual, 2024-12-31) — Interest Income Non Operating: 113728.00
IVDA cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 15316.00
IVDA balance_sheet (annual, 2024-12-31) — Inventory: 148120.00
IVDA balance_sheet (annual, 2024-12-31) — Invested Capital: 3430659.00
IVDA cash_flow (annual, 2024-12-31) — Investing Cash Flow: -2608.00
IVDA cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 1683970.00
IVDA cash_flow (annual, 2024-12-31) — Issuance Of Debt: 403249.00
IVDA balance_sheet (annual, 2024-12-31) — Line Of Credit: 427025.00
IVDA balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
IVDA balance_sheet (annual, 2024-12-31) — Long Term Debt: 376188.00
IVDA balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 376188.00
IVDA cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 1683970.00
IVDA income_statement (annual, 2024-12-31) — Net Income: -3980820.00
IVDA income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -3980820.00
IVDA income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -3980820.00
IVDA income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -3980820.00
IVDA income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -3980820.00
IVDA cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -3980820.00
IVDA income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -3980820.00
IVDA income_statement (annual, 2024-12-31) — Net Interest Income: 87545.00
IVDA cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 576449.00
IVDA cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 498195.00
IVDA income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 87545.00
IVDA balance_sheet (annual, 2024-12-31) — Net PPE: 68677.00
IVDA cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -2608.00
IVDA cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 78254.00
IVDA balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 2505439.00
IVDA income_statement (annual, 2024-12-31) — Normalized EBITDA: -3890447.00
IVDA income_statement (annual, 2024-12-31) — Normalized Income: -3980820.00
IVDA cash_flow (annual, 2024-12-31) — Operating Cash Flow: -4419748.00
IVDA income_statement (annual, 2024-12-31) — Operating Income: -4070303.00
IVDA income_statement (annual, 2024-12-31) — Operating Revenue: 6020639.00
IVDA balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 2808071.00
IVDA balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 122007.00
IVDA balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -280209.00
IVDA income_statement (annual, 2024-12-31) — Other Gand A: 5008587.00
IVDA income_statement (annual, 2024-12-31) — Other Income Expense: 34323.00
IVDA cash_flow (annual, 2024-12-31) — Other Non Cash Items: 90000.00
IVDA cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 0.00
IVDA balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 84424.00
IVDA income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 34323.00
IVDA balance_sheet (annual, 2024-12-31) — Other Properties: 68677.00
IVDA balance_sheet (annual, 2024-12-31) — Payables: 1748857.00
IVDA balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 1748857.00
IVDA balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
IVDA balance_sheet (annual, 2024-12-31) — Prepaid Assets: 435052.00
IVDA balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 435052.00
IVDA income_statement (annual, 2024-12-31) — Pretax Income: -3948435.00
IVDA cash_flow (annual, 2024-12-31) — Purchase Of PPE: -2608.00
IVDA cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: 7.00
IVDA balance_sheet (annual, 2024-12-31) — Receivables: 1277635.00
IVDA income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 4719005.00
IVDA income_statement (annual, 2024-12-31) — Reconciled Depreciation: 31805.00
IVDA cash_flow (annual, 2024-12-31) — Repayment Of Debt: -324995.00
IVDA income_statement (annual, 2024-12-31) — Research And Development: 363350.00
IVDA balance_sheet (annual, 2024-12-31) — Restricted Cash: 29013.00
IVDA balance_sheet (annual, 2024-12-31) — Retained Earnings: -53176717.00
IVDA income_statement (annual, 2024-12-31) — Selling General And Administration: 5008587.00
IVDA balance_sheet (annual, 2024-12-31) — Share Issued: 2808071.00
IVDA cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 403249.00
IVDA cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -324995.00
IVDA cash_flow (annual, 2024-12-31) — Stock Based Compensation: 122600.00
IVDA cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 97000.00
IVDA balance_sheet (annual, 2024-12-31) — Stockholders Equity: 2505439.00
IVDA balance_sheet (annual, 2024-12-31) — Tangible Book Value: 2505439.00
IVDA income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
IVDA income_statement (annual, 2024-12-31) — Tax Provision: 32385.00
IVDA income_statement (quarterly, 2024-12-31) — Tax Provision: -79.00
IVDA income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
IVDA balance_sheet (annual, 2024-12-31) — Total Assets: 5179516.00
IVDA balance_sheet (annual, 2024-12-31) — Total Capitalization: 2881627.00
IVDA balance_sheet (annual, 2024-12-31) — Total Debt: 925220.00
IVDA balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 2505439.00
IVDA income_statement (annual, 2024-12-31) — Total Expenses: 10090942.00
IVDA balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 2674077.00
IVDA balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 153101.00
IVDA balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 376188.00
IVDA income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -4070303.00
IVDA balance_sheet (annual, 2024-12-31) — Working Capital: 2728526.00
IVDA income_statement (quarterly, 2025-03-31) — +Operating Expense: 1123770.00
IVDA income_statement (quarterly, 2025-03-31) — +Total Revenue: 1474576.00
IVDA balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 795646.00
IVDA balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 819750.00
IVDA balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 55962337.00
IVDA income_statement (quarterly, 2025-03-31) — Basic Average Shares: 2808071.00
IVDA income_statement (quarterly, 2025-03-31) — Basic EPS: -0.28
IVDA cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 2658300.00
IVDA balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 181531.00
IVDA balance_sheet (quarterly, 2025-03-31) — Capital Stock: 28.00
IVDA balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 2490482.00
IVDA balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2490482.00
IVDA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 839.00
IVDA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 109.00
IVDA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -125966.00
IVDA cash_flow (quarterly, 2025-03-31) — Change In Inventory: -69508.00
IVDA cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 154271.00
IVDA cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -1137.00
IVDA cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 147920.00
IVDA cash_flow (quarterly, 2025-03-31) — Change In Payable: -29010.00
IVDA cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -29010.00
IVDA cash_flow (quarterly, 2025-03-31) — Change In Receivables: 457885.00
IVDA cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 660421.00
IVDA cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 457885.00
IVDA cash_flow (quarterly, 2025-03-31) — Changes In Cash: -125018.00
IVDA balance_sheet (quarterly, 2025-03-31) — Common Stock: 28.00
IVDA balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1700887.00
IVDA cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
IVDA cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
IVDA income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1186365.00
IVDA balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 881460.00
IVDA balance_sheet (quarterly, 2025-03-31) — Current Assets: 4212653.00
IVDA balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 33504.00
IVDA balance_sheet (quarterly, 2025-03-31) — Current Debt: 585228.00
IVDA balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 618732.00
IVDA balance_sheet (quarterly, 2025-03-31) — Current Deferred Assets: 359388.00
IVDA balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 42742.00
IVDA balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 42742.00
IVDA balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2338580.00
IVDA cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 7285.00
IVDA cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 7285.00
IVDA income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 2808071.00
IVDA income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.28
IVDA income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -793672.00
IVDA income_statement (quarterly, 2025-03-31) — EBIT: -787876.00
IVDA income_statement (quarterly, 2025-03-31) — EBITDA: -780591.00
IVDA cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -14194.00
IVDA cash_flow (quarterly, 2025-03-31) — End Cash Position: 2519088.00
IVDA cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 839.00
IVDA cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -125966.00
IVDA balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -291089.00
IVDA income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1090770.00
IVDA balance_sheet (quarterly, 2025-03-31) — Gross PPE: 243951.00
IVDA income_statement (quarterly, 2025-03-31) — Gross Profit: 288211.00
IVDA cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 476.00
IVDA income_statement (quarterly, 2025-03-31) — Interest Expense: 5796.00
IVDA income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 5796.00
IVDA income_statement (quarterly, 2025-03-31) — Interest Income: 15261.00
IVDA income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 15261.00
IVDA cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 6063.00
IVDA balance_sheet (quarterly, 2025-03-31) — Inventory: 217628.00
IVDA balance_sheet (quarterly, 2025-03-31) — Invested Capital: 2626946.00
IVDA cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 109.00
IVDA cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
IVDA cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 37909.00
IVDA balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 464934.00
IVDA balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 148027.00
IVDA balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 340831.00
IVDA balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 488858.00
IVDA cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
IVDA income_statement (quarterly, 2025-03-31) — Net Income: -793672.00
IVDA income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -793672.00
IVDA income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -793672.00
IVDA income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -793672.00
IVDA income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -793672.00
IVDA cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -793672.00
IVDA income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -793672.00
IVDA income_statement (quarterly, 2025-03-31) — Net Interest Income: 9465.00
IVDA cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 839.00
IVDA cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -37070.00
IVDA income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 9465.00
IVDA balance_sheet (quarterly, 2025-03-31) — Net PPE: 243951.00
IVDA cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 109.00
IVDA cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 37909.00
IVDA balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1700887.00
IVDA income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -780591.00
IVDA income_statement (quarterly, 2025-03-31) — Normalized Income: -793672.00
IVDA cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -125966.00
IVDA income_statement (quarterly, 2025-03-31) — Operating Income: -835559.00
IVDA income_statement (quarterly, 2025-03-31) — Operating Revenue: 1474576.00
IVDA balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 2808071.00
IVDA balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 296799.00
IVDA balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 120294.00
IVDA balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -291089.00
IVDA income_statement (quarterly, 2025-03-31) — Other Gand A: 1090770.00
IVDA income_statement (quarterly, 2025-03-31) — Other Income Expense: 32422.00
IVDA balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 71721.00
IVDA income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 32422.00
IVDA balance_sheet (quarterly, 2025-03-31) — Other Properties: 243951.00
IVDA balance_sheet (quarterly, 2025-03-31) — Payables: 795646.00
IVDA balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1677106.00
IVDA balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
IVDA income_statement (quarterly, 2025-03-31) — Pretax Income: -793672.00
IVDA balance_sheet (quarterly, 2025-03-31) — Receivables: 819750.00
IVDA income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1186365.00
IVDA income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 7285.00
IVDA cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
IVDA cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
IVDA income_statement (quarterly, 2025-03-31) — Research And Development: 33000.00
IVDA balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 28606.00
IVDA balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -53970389.00
IVDA cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 109.00
IVDA income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1090770.00
IVDA balance_sheet (quarterly, 2025-03-31) — Share Issued: 2808071.00
IVDA cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 37909.00
IVDA cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: 0.00
IVDA cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 0.00
IVDA balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1700887.00
IVDA balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1700887.00
IVDA income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IVDA income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
IVDA income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
IVDA balance_sheet (quarterly, 2025-03-31) — Total Assets: 4528325.00
IVDA balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 2041718.00
IVDA balance_sheet (quarterly, 2025-03-31) — Total Debt: 1107590.00
IVDA balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1700887.00
IVDA income_statement (quarterly, 2025-03-31) — Total Expenses: 2310135.00
IVDA balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2827438.00
IVDA balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 315672.00
IVDA balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 488858.00
IVDA income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -835559.00
IVDA balance_sheet (quarterly, 2025-03-31) — Working Capital: 1874073.00
IVDA income_statement (quarterly, 2025-06-30) — +Operating Expense: 977129.00
IVDA income_statement (quarterly, 2025-06-30) — +Total Revenue: 1527907.00
IVDA balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 862157.00
IVDA balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1366457.00
IVDA balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 56185931.00
IVDA income_statement (quarterly, 2025-06-30) — Basic Average Shares: 2837226.00
IVDA income_statement (quarterly, 2025-06-30) — Basic EPS: -0.20
IVDA cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 2519088.00
IVDA balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 178074.00
IVDA balance_sheet (quarterly, 2025-06-30) — Capital Stock: 29.00
IVDA balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1592209.00
IVDA balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1592209.00
IVDA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 317995.00
IVDA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1310.00
IVDA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -1332108.00
IVDA cash_flow (quarterly, 2025-06-30) — Change In Inventory: -57297.00
IVDA cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -28369.00
IVDA cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -3457.00
IVDA cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -129015.00
IVDA cash_flow (quarterly, 2025-06-30) — Change In Payable: -9070.00
IVDA cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -9070.00
IVDA cash_flow (quarterly, 2025-06-30) — Change In Receivables: -546707.00
IVDA cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -773915.00
IVDA cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -546707.00
IVDA cash_flow (quarterly, 2025-06-30) — Changes In Cash: -1015423.00
IVDA balance_sheet (quarterly, 2025-06-30) — Common Stock: 29.00
IVDA balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1480557.00
IVDA cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 223595.00
IVDA income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1083138.00
IVDA balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 840463.00
IVDA balance_sheet (quarterly, 2025-06-30) — Current Assets: 4084903.00
IVDA balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 36826.00
IVDA balance_sheet (quarterly, 2025-06-30) — Current Debt: 655113.00
IVDA balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 691939.00
IVDA balance_sheet (quarterly, 2025-06-30) — Current Deferred Assets: 488403.00
IVDA balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 8157.00
IVDA balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 8157.00
IVDA balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 2402716.00
IVDA cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 6056.00
IVDA cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 6056.00
IVDA income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 2837226.00
IVDA income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.20
IVDA income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -564249.00
IVDA income_statement (quarterly, 2025-06-30) — EBIT: -522355.00
IVDA income_statement (quarterly, 2025-06-30) — EBITDA: -516299.00
IVDA cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 122769.00
IVDA cash_flow (quarterly, 2025-06-30) — End Cash Position: 1626434.00
IVDA cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 317995.00
IVDA cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1333309.00
IVDA balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -170765.00
IVDA income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 925629.00
IVDA balance_sheet (quarterly, 2025-06-30) — Gross PPE: 226773.00
IVDA income_statement (quarterly, 2025-06-30) — Gross Profit: 444769.00
IVDA cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 0.00
IVDA income_statement (quarterly, 2025-06-30) — Interest Expense: 12116.00
IVDA income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 12116.00
IVDA income_statement (quarterly, 2025-06-30) — Interest Income: 10280.00
IVDA income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 10280.00
IVDA cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 0.00
IVDA balance_sheet (quarterly, 2025-06-30) — Inventory: 274925.00
IVDA balance_sheet (quarterly, 2025-06-30) — Invested Capital: 2501016.00
IVDA cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1310.00
IVDA cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 223595.00
IVDA balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 529525.00
IVDA balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 141248.00
IVDA balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 365346.00
IVDA balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 506594.00
IVDA cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 223595.00
IVDA income_statement (quarterly, 2025-06-30) — Net Income: -564249.00
IVDA income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -564249.00
IVDA income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -564249.00
IVDA income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -564249.00
IVDA income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -564249.00
IVDA cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -564249.00
IVDA income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -564249.00
IVDA income_statement (quarterly, 2025-06-30) — Net Interest Income: -1836.00
IVDA cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 94400.00
IVDA cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 29809.00
IVDA income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1836.00
IVDA balance_sheet (quarterly, 2025-06-30) — Net PPE: 226773.00
IVDA cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1310.00
IVDA cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 64591.00
IVDA balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1480557.00
IVDA income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -516299.00
IVDA income_statement (quarterly, 2025-06-30) — Normalized Income: -564249.00
IVDA cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1332108.00
IVDA income_statement (quarterly, 2025-06-30) — Operating Income: -532360.00
IVDA income_statement (quarterly, 2025-06-30) — Operating Revenue: 1527907.00
IVDA balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 2906726.00
IVDA balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 328684.00
IVDA balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 125588.00
IVDA balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -170765.00
IVDA income_statement (quarterly, 2025-06-30) — Other Gand A: 925629.00
IVDA income_statement (quarterly, 2025-06-30) — Other Income Expense: -275.00
IVDA balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 78191.00
IVDA income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -275.00
IVDA balance_sheet (quarterly, 2025-06-30) — Other Properties: 226773.00
IVDA balance_sheet (quarterly, 2025-06-30) — Payables: 862157.00
IVDA balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1702620.00
IVDA balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
IVDA income_statement (quarterly, 2025-06-30) — Pretax Income: -534471.00
IVDA balance_sheet (quarterly, 2025-06-30) — Receivables: 1366457.00
IVDA income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1083138.00
IVDA income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 6056.00
IVDA income_statement (quarterly, 2025-06-30) — Research And Development: 51500.00
IVDA balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 34225.00
IVDA balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -54534638.00
IVDA income_statement (quarterly, 2025-06-30) — Selling General And Administration: 925629.00
IVDA balance_sheet (quarterly, 2025-06-30) — Share Issued: 2906726.00
IVDA balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1480557.00
IVDA balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1480557.00
IVDA income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
IVDA income_statement (quarterly, 2025-06-30) — Tax Provision: 29778.00
IVDA income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
IVDA balance_sheet (quarterly, 2025-06-30) — Total Assets: 4389867.00
IVDA balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1845903.00
IVDA balance_sheet (quarterly, 2025-06-30) — Total Debt: 1198533.00
IVDA balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1480557.00
IVDA income_statement (quarterly, 2025-06-30) — Total Expenses: 2060267.00
IVDA balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2909310.00
IVDA balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 304964.00
IVDA balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 506594.00
IVDA income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -532360.00
IVDA balance_sheet (quarterly, 2025-06-30) — Working Capital: 1682187.00
IVDA income_statement (quarterly, 2025-09-30) — +Operating Expense: 731580.00
IVDA income_statement (quarterly, 2025-09-30) — +Total Revenue: 1651787.00
IVDA balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 920774.00
IVDA balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1324086.00
IVDA balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 58736166.00
IVDA income_statement (quarterly, 2025-09-30) — Basic Average Shares: 3045753.00
IVDA income_statement (quarterly, 2025-09-30) — Basic EPS: -0.07
IVDA cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1626434.00
IVDA balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 167412.00
IVDA balance_sheet (quarterly, 2025-09-30) — Capital Stock: 45.00
IVDA balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 3298474.00
IVDA balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 3298474.00
IVDA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 2064115.00
IVDA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 1201.00
IVDA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -317006.00
IVDA cash_flow (quarterly, 2025-09-30) — Change In Inventory: 27409.00
IVDA cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -5819.00
IVDA cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -10662.00
IVDA cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 250654.00
IVDA cash_flow (quarterly, 2025-09-30) — Change In Payable: -469876.00
IVDA cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -469876.00
IVDA cash_flow (quarterly, 2025-09-30) — Change In Receivables: 42371.00
IVDA cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -165923.00
IVDA cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 42371.00
IVDA cash_flow (quarterly, 2025-09-30) — Changes In Cash: 1748310.00
IVDA balance_sheet (quarterly, 2025-09-30) — Common Stock: 45.00
IVDA balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 3768242.00
IVDA cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 2482751.00
IVDA income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1134510.00
IVDA balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 312166.00
IVDA balance_sheet (quarterly, 2025-09-30) — Current Assets: 5481219.00
IVDA balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 40390.00
IVDA balance_sheet (quarterly, 2025-09-30) — Current Debt: 295441.00
IVDA balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 335831.00
IVDA balance_sheet (quarterly, 2025-09-30) — Current Deferred Assets: 237749.00
IVDA balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 7962.00
IVDA balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 7962.00
IVDA balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1576733.00
IVDA cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2721.00
IVDA cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 2721.00
IVDA income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 3045753.00
IVDA income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.07
IVDA income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -221304.00
IVDA income_statement (quarterly, 2025-09-30) — EBIT: -209065.00
IVDA income_statement (quarterly, 2025-09-30) — EBITDA: -206344.00
IVDA cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -43468.00
IVDA cash_flow (quarterly, 2025-09-30) — End Cash Position: 3331276.00
IVDA cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 2064115.00
IVDA cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -315805.00
IVDA balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -212027.00
IVDA income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 705830.00
IVDA balance_sheet (quarterly, 2025-09-30) — Gross PPE: 212464.00
IVDA income_statement (quarterly, 2025-09-30) — Gross Profit: 517277.00
IVDA cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 11958.00
IVDA income_statement (quarterly, 2025-09-30) — Interest Expense: 11574.00
IVDA income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 11574.00
IVDA income_statement (quarterly, 2025-09-30) — Interest Income: 5260.00
IVDA income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 5260.00
IVDA cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 8669.00
IVDA balance_sheet (quarterly, 2025-09-30) — Inventory: 247516.00
IVDA balance_sheet (quarterly, 2025-09-30) — Invested Capital: 4370065.00
IVDA cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 1201.00
IVDA cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 2482751.00
IVDA balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 164134.00
IVDA balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 127022.00
IVDA balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 306382.00
IVDA balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 433404.00
IVDA cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 2482751.00
IVDA income_statement (quarterly, 2025-09-30) — Net Income: -221304.00
IVDA income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -221304.00
IVDA income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -221304.00
IVDA income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -221304.00
IVDA income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -221304.00
IVDA cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -221304.00
IVDA income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -221304.00
IVDA income_statement (quarterly, 2025-09-30) — Net Interest Income: -6314.00
IVDA cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -418636.00
IVDA cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -53245.00
IVDA income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -6314.00
IVDA balance_sheet (quarterly, 2025-09-30) — Net PPE: 212464.00
IVDA cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 1201.00
IVDA cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -365391.00
IVDA balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 3768242.00
IVDA income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -206344.00
IVDA income_statement (quarterly, 2025-09-30) — Normalized Income: -221304.00
IVDA cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -317006.00
IVDA income_statement (quarterly, 2025-09-30) — Operating Income: -214303.00
IVDA income_statement (quarterly, 2025-09-30) — Operating Revenue: 1651787.00
IVDA balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 4457444.00
IVDA balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 340592.00
IVDA balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 131307.00
IVDA balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -212027.00
IVDA income_statement (quarterly, 2025-09-30) — Other Gand A: 705830.00
IVDA income_statement (quarterly, 2025-09-30) — Other Income Expense: -22.00
IVDA balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 84696.00
IVDA income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -22.00
IVDA balance_sheet (quarterly, 2025-09-30) — Other Properties: 212464.00
IVDA balance_sheet (quarterly, 2025-09-30) — Payables: 920774.00
IVDA balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1232940.00
IVDA balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
IVDA income_statement (quarterly, 2025-09-30) — Pretax Income: -220639.00
IVDA cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 1201.00
IVDA balance_sheet (quarterly, 2025-09-30) — Receivables: 1324086.00
IVDA income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1134510.00
IVDA income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2721.00
IVDA income_statement (quarterly, 2025-09-30) — Research And Development: 25750.00
IVDA balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 32802.00
IVDA balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -54755942.00
IVDA income_statement (quarterly, 2025-09-30) — Selling General And Administration: 705830.00
IVDA balance_sheet (quarterly, 2025-09-30) — Share Issued: 4457444.00
IVDA balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 3768242.00
IVDA balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 3768242.00
IVDA income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
IVDA income_statement (quarterly, 2025-09-30) — Tax Provision: 665.00
IVDA income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
IVDA balance_sheet (quarterly, 2025-09-30) — Total Assets: 5778379.00
IVDA balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 4074624.00
IVDA balance_sheet (quarterly, 2025-09-30) — Total Debt: 769235.00
IVDA balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 3768242.00
IVDA income_statement (quarterly, 2025-09-30) — Total Expenses: 1866090.00
IVDA balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2010137.00
IVDA balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 297160.00
IVDA balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 433404.00